주요 콘텐츠로 건너뛰기

귀하의 브라우저가 완벽하게 지원되지 않습니다. 옵션이 있는 경우 최신 버전으로 업그레이드하거나 Mozilla Firefox, Microsoft Edge, Google Chrome 또는 Safari 14 이상을 사용하세요. 가능하지 않거나 지원이 필요한 경우 피드백을 보내주세요.

이 새로운 경험에 대한 귀하의 의견에 감사드립니다.의견을 말씀해 주세요 새 탭/창에서 열기

Elsevier
엘스비어와 함께 출판

Highlights

Highlights are three to five (three to four for Cell Press articles) bullet points that help increase the discoverability of your article via search engines. These bullet points should capture the novel results of your research as well as new methods that were used during the study (if any). Think of them as the "elevator pitch" of your article. Please include terms that you know your readers will be looking for online. Don't try to capture all ideas, concepts or conclusions as highlights are meant to be short: 85 characters or fewer, including spaces.

Highlights offer your paper a considerable advantage in the online world, as they ensure that search engines pick up your article and match it to the right audience. (Nowadays, machines read your work just as often as humans do!). Highlights have been proven to widen the reach of your work and help to ensure that your article is brought to the attention of interested colleagues, both inside and outside your usual research community. Apart from a wider distribution of your research, we hope that this will also lead to new collaborations and help accelerate the pace of science.

The small print

  • Not part of editorial consideration and aren't required until the final files stage

  • Only required for full research articles

  • Must be provided as a Word document— select "Highlights" from the drop-down list when uploading files

  • Each Highlight can be no more than 85 characters, including spaces

  • No jargon, acronyms, or abbreviations: aim for a general audience and use keywords

  • Consider the reader - Highlights are the first thing they'll see

Examples

From: Cancer Cell, Volume 32, Issue 2, 14 August 2017, Pages 169-184.e7 새 탭/창에서 열기

Highlights

  • Metastases mostly disseminate late from primary breast tumors, keeping most drivers

  • Drivers at relapse sample from a wider range of cancer genes than in primary tumors

  • Mutations in SWI-SNF complex and inactivated JAK-STAT signaling enriched at relapse

  • Mutational processes similar in primary and relapse; radiotherapy can damage genome

From: Learning and Instruction, Volume 21, Issue 6, December 2011, 746-756 새 탭/창에서 열기

Highlights

  • Fading of a script alone does not foster domain-general strategy knowledge

  • Performance of the strategy declines during the fading of a script

  • Monitoring by a peer keeps performance of the strategy up during script fading

  • Performance of a strategy after fading fosters domain-general strategy knowledge

  • Fading and monitoring by a peer combined foster domain-general strategy knowledge